First Page | Document Content | |
---|---|---|
![]() Date: 2014-11-19 14:32:05Communication Forward-looking statement Percutaneous aortic valve replacement Mitral valve replacement Cardiac surgery Valvular heart disease Business law | Add to Reading List |
![]() | Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™,DocID: 1rff4 - View Document |
![]() | Influence of QRS Infarct Score and QRS Duration prior to Transcatheter Aortic Valve Replacement on Follow-up Left Ventricular End Systolic Volume in Patients with New Persistent Left Bundle Branch Block Laura G.J. HanninDocID: 1qYwu - View Document |
![]() | FINAL COPY Vivasure Medical Receives CE Mark for First and Only Fully Bioabsorbable PercutaneousDocID: 1qoGe - View Document |
![]() | EXTRACTING GEOMETRIC FEATURES OF AORTIC VALVE ANNULUS MOTION FROM DYNAMIC MRI FOR GUIDING INTERVENTIONS Nikhil V. Navkar1,2 , Erol Yeniaras2 , Dipan J. Shah3 , Nikolaos V. Tsekos2 , Zhigang Deng1 1 Computer Graphics andDocID: 1oDqb - View Document |
![]() | PDF DocumentDocID: 1oBs5 - View Document |